Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.

Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.

Item
http://www.wikidata.org/entity/Q35861249
Trial WatchRegulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingTargeted immune therapy of ovarian cancerImmunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?TGFβ in T cell biology and tumor immunity: Angel or devil?Interferon-gamma producing regulatory T cells as a diagnostic and therapeutic tool in organ transplantation.Dendritic cells enhance the activity of human MUC1-stimulated mononuclear cells against breast cancer.Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.Mathematical model approach to describe tumour response in mice after vaccine administration and its applicability to immune-stimulatory cytokine-based strategiesMUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge.Natural and induced T regulatory cells in cancer.Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.Update on Mucin-1 immunotherapy in cancer: a clinical perspective.IL-10 modulation of virus clearance and disease in mice with alphaviral encephalomyelitis.
P2860

Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.

Item
http://www.wikidata.org/entity/Q35861249
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Immunotherapy with IL-10- and ...... patients with ovarian cancer.
@ast
Immunotherapy with IL-10- and ...... patients with ovarian cancer.
@en
type
label
Immunotherapy with IL-10- and ...... patients with ovarian cancer.
@ast
Immunotherapy with IL-10- and ...... patients with ovarian cancer.
@en
prefLabel
Immunotherapy with IL-10- and ...... patients with ovarian cancer.
@ast
Immunotherapy with IL-10- and ...... patients with ovarian cancer.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Immunotherapy with IL-10- and ...... patients with ovarian cancer.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932